全文获取类型
收费全文 | 748篇 |
免费 | 39篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 28篇 |
妇产科学 | 4篇 |
基础医学 | 153篇 |
口腔科学 | 2篇 |
临床医学 | 61篇 |
内科学 | 128篇 |
皮肤病学 | 3篇 |
神经病学 | 85篇 |
特种医学 | 17篇 |
外科学 | 124篇 |
综合类 | 10篇 |
一般理论 | 2篇 |
预防医学 | 68篇 |
眼科学 | 5篇 |
药学 | 26篇 |
中国医学 | 12篇 |
肿瘤学 | 54篇 |
出版年
2022年 | 3篇 |
2021年 | 13篇 |
2020年 | 22篇 |
2019年 | 10篇 |
2018年 | 15篇 |
2017年 | 12篇 |
2016年 | 7篇 |
2015年 | 20篇 |
2014年 | 34篇 |
2013年 | 48篇 |
2012年 | 67篇 |
2011年 | 40篇 |
2010年 | 29篇 |
2009年 | 37篇 |
2008年 | 61篇 |
2007年 | 44篇 |
2006年 | 41篇 |
2005年 | 38篇 |
2004年 | 47篇 |
2003年 | 43篇 |
2002年 | 31篇 |
2001年 | 6篇 |
2000年 | 8篇 |
1999年 | 5篇 |
1998年 | 8篇 |
1997年 | 7篇 |
1996年 | 7篇 |
1995年 | 9篇 |
1994年 | 8篇 |
1993年 | 13篇 |
1992年 | 6篇 |
1991年 | 7篇 |
1990年 | 5篇 |
1989年 | 3篇 |
1988年 | 2篇 |
1987年 | 2篇 |
1986年 | 3篇 |
1985年 | 1篇 |
1984年 | 3篇 |
1983年 | 5篇 |
1982年 | 8篇 |
1981年 | 1篇 |
1980年 | 4篇 |
1979年 | 1篇 |
1978年 | 1篇 |
1977年 | 1篇 |
1976年 | 1篇 |
1975年 | 2篇 |
1974年 | 1篇 |
排序方式: 共有790条查询结果,搜索用时 31 毫秒
1.
2.
Vilde D. Haakensen Anand Khadse Vandana Sandhu Ann Rita Halvorsen Steinar K. Solberg Lars H. Jørgensen Odd Terje Brustugun Elin H. Kure Åslaug Helland 《International journal of cancer. Journal international du cancer》2020,147(10):2957-2966
Personalised cancer treatment depends on identification of therapeutically relevant biological subgroups of patients for assessing effect of treatment and to discover new therapeutic options. By analyses in heterogeneous patient populations, the effects may be lost in noise. Squamous cell carcinoma of the lung is a major killer worldwide. Despite recent advances, mortality is high and response to therapies varies greatly from patient to patient. Target search in biologically relevant subgroups may identify treatment options not so far discovered. A total of 198 patients undergoing surgery for squamous cell carcinomas of the lung were included in the study. The tumours were analysed for copy number alterations (n = 152) and gene expression from tumour (n = 188) and normal lung (n = 21), with both data levels present in 140 patients. We studied alterations in tumours harbouring mutations in TP53 and in previously published gene expression subtypes. Genes with consistent alterations in both genomic levels were identified as putative biomarkers. Results were validated in TCGA. The most convincing biomarker in TP53 mutated squamous cell carcinomas of the lung was BIRC5 with amplification in 36% of mutated samples, 5% in wild-type samples and a 17%-fold change of expression between TP53 mutated tumours and normal lung tissue. BIRC5 was significantly altered in the classical and primitive subtypes. We suggest BIRC5 as a putative predictive biomarker and putative druggable target in squamous cell lung carcinomas harbouring TP53 mutation or classified as classical and primitive subtypes. 相似文献
3.
Christoffer Bugge Erik Magnus Sæther Odd Terje Brustugun Ivar Sønbø Kristiansen 《Health policy (Amsterdam, Netherlands)》2021,125(8):1100-1107
BackgroundThe broader cost consequences of diseases may be of interest for a wide range of stakeholders. We aimed to estimate all relevant societal costs of cancer and to provide insight into the relative magnitude of the different cost categories.MethodWe used data from eight different health and work-related registries in Norway. Direct, indirect, and intangible costs (value of lost life years) were estimated over a period of one year with a combination of a top-down and a bottom-up costing approach.ResultsThe indirect costs (EUR 1,997 million per year) are almost as high as direct costs (EUR 2,154 million), and the value of lost life years and quality of life represents the greatest cost related to cancer (EUR 18,200 million). In addition, cancer is associated with other costs which are commonly omitted from cost-of-illness analyses, including informal nursing (EUR 306 million), patient time costs (EUR 85 million), and excess costs of using public funds (EUR 439 million). Breast and cervical cancer had relatively high work absenteeism costs, while pancreatic and lung cancer had relatively high production costs due to premature deaths.DiscussionDirect health care costs represent small proportions of the total societal costs of cancer. Costs commonly omitted in cost-of-illness analyses represent a significant cost and should be measured and valued in these analyses. 相似文献
4.
5.
Blood Flow Imaging in Transesophageal Echocardiography during Atrial Septal Defect Closure: A Comparison with the Current References 下载免费PDF全文
Siri Ann Nyrnes M.D. Lasse Løvstakken M.Sc. Ph.D. Gaute Døhlen M.D. Ph.D. Eirik Skogvoll M.D. Ph.D. Hans Torp M.Sc. Dr.Tech. Terje Skjærpe M.D. Ph.D. Gunnar Norgård M.D. Ph.D. Stein Samstad M.D. Ph.D. Torbjørn Graven M.D. Bjørn Olav Haugen M.D. Ph.D. 《Echocardiography (Mount Kisco, N.Y.)》2015,32(1):34-41
6.
7.
8.
Ivar Risnes Michael Abdelnoor Geir Ulimoen Stein Erik Rynning Terje Veel Jan L Svennevig Runar Lundblad Arne Borthne 《International wound journal》2014,11(6):594-600
Mediastinitis after coronary artery bypass grafting (CABG) gives a longstanding chronic inflammation and has a detrimental negative effect on long‐term survival. For this reason, we aimed to study the effect of mediastinitis on graft patency after CABG. The epidemiologic design was of an exposed (mediastinitis, n = 41) versus non‐exposed (non‐mediastinitis, controls, n = 41) cohort with two endpoints: (i) obstruction of saphenous vein grafts (SVG) and (ii) obstruction of the internal mammary artery (IMA) grafts. The graft patency was evaluated with coronary CT‐angiography examination at a median follow‐up of 2·7 years. The number of occluded SVG in the mediastinitis group was 18·9% versus 15·5% in the control group. Using generalized estimating equations model with exchangeable matrix, and confounding effect of ischaemic time and patients age, we found no significant association between presence of mediastinitis and SVG obstruction [rate ratio (RR) = 0·96, 95% CI (0·52–2·67), P = 0·697]. The number of occluded IMA grafts was 10·5% in the mediastinitis group and 2·4% in the control group. Using the Poisson regression model, we estimated RR = 5·48, 95% CI (1·43–21·0) and P = 0·013. There was a significant association between mediastinitis and IMA graft obstruction, when controlling for the confounding effect of ischaemic time, body mass index, presence of diabetes mellitus and the number of diseased vessels. Presence of mediastinitis increases the risk of IMA graft obstruction. This may confirm the importance of inflammation as a major contributor to the pathogenesis of atherosclerosis and explain the negative effect of mediastinitis on a long‐term survival. 相似文献
9.
Ivar Risnes Michael Abdelnoor Terje Veel Jan Ludvig Svennevig Runar Lundblad Stein Erik Rynning 《International wound journal》2014,11(2):177-182
Mediastinitis is treated with either vacuum‐assisted closure (VAC) or traditional closed drainage (TCD) with irrigation. The aim of the study was to determine the effect of the two treatments on mortality and re‐infection rate in a source population, using 21 314 consecutive patients undergoing isolated coronary artery bypass grafting (CABG) from January 1997 to October 2010. Median observation time was 2·9 years in the VAC group and 8·0 years in the TCD group. The epidemiological design was of an exposed (VAC, n = 64) versus non‐exposed (TCD, n = 66) cohort with two endpoints: (1) mortality and (2) failure of sternal wound healing or re‐infection. The crude effect of treatment technique versus endpoint was estimated by univariate analysis. Stratification analysis by the Mantel–Haenszel method was performed to quantify confounders and to pinpoint effect modifiers. Adjustment for confounders was performed using Cox regression analysis. Mediastinitis was diagnosed 6–105 (median 14) days after primary operation in the VAC group and 13 (5–29) days in the TCD group. There was no difference between groups in long‐term survival. Failure of sternal wound healing or re‐infection occurred less frequently in the VAC group (6%) than in the TCD group (21%; relative risk = 0·29, 95% CI = 0·06–0·88, P = 0·01). There are concerns for increase in right ventricle rupture in VAC compared with TCD. There was no difference in survival after VAC therapy and TCD therapy of post‐CABG mediastinitis. Failure of sternal wound healing or re‐infection was more common after TCD therapy. 相似文献
10.
Stefan Huhnstock Svein Svenningsen Are H Pripp Terje Terjesen Ola Wiig 《Acta orthopaedica》2014,85(5):506-512